| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |